Nintedanib
Nintedanib
Methyl-3-((Z)-{4-[N-methyl-2-(4-methylpiperazin-1-yl)acetamido]anilino}phenylmethyliden)-2-oxo-2,3-dihydro-1H-indol-6-carboxylat
Stoffgruppe
Antineoplastisches Mittel (Proteinkinase-Inhibitor)
Halbwertszeit
10-15 h